Celularity Inc. Files 8-K on Financials and Other Events
Ticker: CELUW · Form: 8-K · Filed: Nov 7, 2024 · CIK: 1752828
Sentiment: neutral
Topics: financial-condition, exhibits, reporting
Related Tickers: CELU
TL;DR
CELU filed an 8-K on Nov 7, 2024, covering financials and other events. Details are in the exhibits.
AI Summary
Celularity Inc. filed an 8-K on November 7, 2024, reporting on its financial condition and other events. The filing includes financial statements and exhibits, but does not detail specific financial results or significant events in the provided text.
Why It Matters
This filing provides an update on Celularity Inc.'s financial condition and any other material events, which is crucial for investors to assess the company's ongoing operations and potential risks.
Risk Assessment
Risk Level: medium — The filing is a standard 8-K for financial reporting and other events, but without specific details on the nature of these events or financial performance, the risk level is assessed as medium.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- November 7, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Celularity Inc.?
The primary purpose of this 8-K filing is to report on Celularity Inc.'s Results of Operations and Financial Condition, as well as Other Events, and to include Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 7, 2024.
What was Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
In which state is Celularity Inc. incorporated?
Celularity Inc. is incorporated in Delaware.
What is Celularity Inc.'s IRS Employer Identification Number?
Celularity Inc.'s IRS Employer Identification Number is 83-1702591.
Filing Stats: 684 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-11-07 08:10:11
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per one-tenth of one share CELUW Th
- $54 million — ear 2024 expected net sales guidance to $54 million to $60 million from its prior guidance
- $60 million — ed net sales guidance to $54 million to $60 million from its prior guidance of $50 million
- $50 million — $60 million from its prior guidance of $50 million to $56 million. Item 9.01 Financial S
- $56 million — om its prior guidance of $50 million to $56 million. Item 9.01 Financial Statements and E
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 18KB
- 0001493152-24-043924.txt ( ) — 290KB
- celu-20241107.xsd (EX-101.SCH) — 4KB
- celu-20241107_def.xml (EX-101.DEF) — 30KB
- celu-20241107_lab.xml (EX-101.LAB) — 36KB
- celu-20241107_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC. Date: November 7, 2024 By: /s/ Robert J. Hariri Robert J. Hariri, M.D., Ph.D. Chairman and CEO